Shigeaki Suzuki Selected Research

Steroids

7/2021	Two-year changes of bone mineral density in steroid-treated myasthenia gravis.
1/2020	Reappraisal of Oral Steroid Therapy for Myasthenia Gravis.
12/2015	Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) after treatment for Hodgkin's lymphoma.
1/2011	[Recurrent syncope due to sick sinus syndrome in a patient with myasthenia gravis associated with thymoma].
1/2010	Two-year treatment with cyclosporine microemulsion for responder myasthenia gravis patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shigeaki Suzuki Research Topics

Disease

52	Myasthenia Gravis 06/2024 - 04/2003
40	Myositis (Idiopathic Inflammatory Myopathies) 04/2024 - 01/2007
29	Muscular Diseases (Myopathy) 04/2024 - 08/2011
14	Thymoma (Thymic Carcinoma) 01/2021 - 12/2003
13	Neoplasms (Cancer) 05/2024 - 11/2008
13	Muscle Weakness 01/2024 - 08/2011
8	Myocarditis (Carditis) 05/2024 - 08/2007
6	Necrosis 04/2024 - 09/2014
6	Antisynthetase syndrome 01/2023 - 01/2017
6	Inclusion Body Myositis 01/2023 - 12/2016
6	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 02/2007
5	Dermatomyositis (Dermatopolymyositis) 01/2023 - 12/2016
5	Brain Ischemia (Cerebral Ischemia) 03/2009 - 01/2002
4	Disease Progression 01/2023 - 01/2007
4	Deglutition Disorders (Dysphagia) 09/2021 - 10/2016
4	Inflammation (Inflammations) 09/2021 - 03/2009
4	Joint Diseases (Joint Disease) 03/2020 - 11/2016
4	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2020 - 11/2016
4	Encephalitis (Encephalitis, Rasmussen) 01/2020 - 01/2007
4	Muscular Dystrophies (Muscular Dystrophy) 01/2019 - 06/2016
4	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 09/2013 - 01/2012
3	Exanthema (Rash) 03/2020 - 01/2017
3	Raynaud Disease (Raynaud's Disease) 03/2020 - 01/2017
3	Myelitis 01/2020 - 01/2007
3	Taste Disorders (Taste Disorder) 03/2019 - 04/2013
3	Polymyositis 01/2018 - 11/2016
3	Atrophy 02/2017 - 09/2014
3	Pure Red-Cell Aplasia 09/2013 - 12/2003
3	Central Nervous System Diseases (CNS Diseases) 03/2009 - 01/2007
3	Infarction (Infarctions) 07/2005 - 01/2002
2	Autoimmune Diseases of the Nervous System 07/2023 - 04/2022
2	Lung Neoplasms (Lung Cancer) 07/2023 - 07/2019
2	Lambert-Eaton Myasthenic Syndrome (Lambert-Eaton Syndrome) 01/2023 - 04/2010
2	Muscular Atrophy (Muscle Atrophy) 01/2023 - 10/2016
2	Diplopia (Double Vision) 09/2021 - 06/2019
2	Renal Cell Carcinoma (Grawitz Tumor) 09/2021 - 01/2020
2	Respiratory Insufficiency (Respiratory Failure) 08/2021 - 10/2016
2	Demyelinating Diseases (Demyelinating Disease) 02/2021 - 02/2017
2	Nephritis 01/2020 - 01/2013
2	Virus Diseases (Viral Diseases) 01/2020 - 03/2011
2	Anaphylaxis (Anaphylactic Shock) 01/2018 - 05/2012
2	Thymus Hyperplasia 01/2018 - 01/2014
2	Lymphoma (Lymphomas) 12/2015 - 01/2015
2	Heart Diseases (Heart Disease) 09/2013 - 04/2013
2	Alopecia Areata 09/2013 - 04/2013

Drug/Important Bio-Agent (IBA)

42	AntibodiesIBA 05/2024 - 01/2007
40	AutoantibodiesIBA 04/2024 - 12/2005
20	Immune Checkpoint InhibitorsIBA 05/2024 - 01/2017
17	Cholinergic ReceptorsIBA 06/2024 - 04/2003
15	Signal Recognition ParticleIBA 04/2024 - 08/2011
10	Oxidoreductases (Dehydrogenase)IBA 04/2024 - 01/2015
9	Biomarkers (Surrogate Marker)IBA 05/2024 - 05/2009
8	Prednisolone (Predate)FDA LinkGeneric 01/2023 - 01/2014
8	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2005
7	NivolumabIBA 07/2023 - 01/2017
7	Creatine Kinase (Creatine Phosphokinase)IBA 01/2023 - 08/2003
7	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 09/2021 - 12/2005
7	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 03/2020 - 11/2011
7	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2020 - 01/2011
6	eculizumab FDA Link 04/2024 - 01/2018
6	RNA (Ribonucleic Acid)IBA 01/2023 - 11/2011
5	Calcineurin InhibitorsIBA 01/2022 - 01/2009
5	ConnectinIBA 09/2021 - 11/2009
5	SteroidsIBA 07/2021 - 01/2010
5	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021 - 04/2006
4	glucose-mannose-glucoseIBA 04/2024 - 01/2020
4	anti-titin autoantibodyIBA 09/2021 - 06/2019
4	Monoclonal AntibodiesIBA 01/2021 - 07/2005
4	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 08/2020 - 01/2015
4	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2019 - 11/2009
4	AntigensIBA 01/2013 - 12/2005
3	HLA-DRB1 Chains (HLA DRB1)IBA 04/2024 - 11/2016
3	Complement System Proteins (Complement)IBA 04/2024 - 01/2018
3	IpilimumabIBA 07/2023 - 09/2017
3	pembrolizumabIBA 07/2020 - 06/2019
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 01/2015
3	Tacrolimus (Prograf)FDA LinkGeneric 01/2014 - 02/2010
3	AutoantigensIBA 09/2013 - 11/2011
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2012 - 01/2010
3	Interleukin-6 (Interleukin 6)IBA 03/2009 - 04/2003
2	muskIBA 06/2024 - 01/2023
2	ravulizumabIBA 04/2024 - 02/2024
2	Phosphotransferases (Kinase)IBA 12/2023 - 06/2019
2	Alkaline PhosphataseIBA 01/2023 - 01/2021
2	Methylprednisolone FDA LinkGeneric 01/2023 - 01/2011
2	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2021 - 01/2017
2	Immunoglobulin G (IgG)IBA 01/2020 - 04/2006
2	Immunoglobulin A (IgA)IBA 01/2020 - 04/2006
2	Ligases (Synthetase)IBA 11/2016 - 01/2016
2	DNA (Deoxyribonucleic Acid)IBA 05/2015 - 01/2013
2	Immunoglobulin M (IgM)IBA 01/2015 - 04/2006
2	GlucocorticoidsIBA 01/2015 - 08/2003
2	EnzymesIBA 01/2015 - 11/2011

Therapy/Procedure

22	Therapeutics 01/2024 - 08/2003
11	Immunotherapy 01/2024 - 11/2008
4	Aftercare (After-Treatment) 09/2021 - 01/2011
4	Hematopoietic Stem Cell Transplantation 01/2020 - 01/2007
3	Plasmapheresis 01/2021 - 01/2011
3	Thymectomy 01/2018 - 12/2003
2	Activities of Daily Living (ADL) 02/2024 - 01/2021